EFFICACY AND TOLERANCE OF MAGNESIUM SULPHATE INTRAVENOUS SLOW VERSUS ELECTRICAL SYRINGE IN THE TREATMENT OF SEVERE PRE-ECLAMPSIA AND ECLAMPSIA.

Abstract

Objective: To appreciate the efficacy and tolerance of magnesium sulphate in two modes of administration in the management of severe preeclampsia and eclampsia. Methods: This was a prospective descriptive and analytical study carried out in two maternity clinics at Cotonou from May 1, 2013 to April 30, 2015. We have registered severe preeclampsia and/or eclampsia during the study period. Magnesium sulphate was administered either to the electric syringe "SE" or to the slow intravenous "IVL". Results: The study involved 720 patients, 426 of whom were in the group "SE" 294 for the group "IVL". Improved consciousness and blood pressure and seizure cessation were more common in the "SE" group than in the "IVL" group. Tolerance was better with fewer side effects in the "SE" group than in the "IVL" group. Conclusion: Administration of magnesium sulfate to the electrical syringe proved to be more effective and more secure.